Presutti Tindamax Clears FDA; Antiprotozoal Agent Will Be Available In July

Tinidazole is approved for four indications: trichomoniasis, giardiasis, amebiasis and amebic liver abscess. The product’s AWP will be $91.20 for a 20-count bottle of 500 mg tablets.

More from Archive

More from Pink Sheet